chr15-90999766-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018668.5(VPS33B):c.1685G>A(p.Ser562Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000396 in 1,614,222 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_018668.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VPS33B | NM_018668.5 | c.1685G>A | p.Ser562Asn | missense_variant | 22/23 | ENST00000333371.8 | NP_061138.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VPS33B | ENST00000333371.8 | c.1685G>A | p.Ser562Asn | missense_variant | 22/23 | 1 | NM_018668.5 | ENSP00000327650.4 | ||
ENSG00000284946 | ENST00000643536.1 | n.1685G>A | non_coding_transcript_exon_variant | 22/35 | ENSP00000494429.1 |
Frequencies
GnomAD3 genomes AF: 0.0000328 AC: 5AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000636 AC: 16AN: 251488Hom.: 1 AF XY: 0.0000956 AC XY: 13AN XY: 135916
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461888Hom.: 1 Cov.: 32 AF XY: 0.0000591 AC XY: 43AN XY: 727248
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152334Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74486
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 21, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). ClinVar contains an entry for this variant (Variation ID: 499620). This variant has not been reported in the literature in individuals affected with VPS33B-related conditions. This variant is present in population databases (rs566630364, gnomAD 0.05%), including at least one homozygous and/or hemizygous individual. This sequence change replaces serine, which is neutral and polar, with asparagine, which is neutral and polar, at codon 562 of the VPS33B protein (p.Ser562Asn). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 03, 2017 | - - |
Arthrogryposis, renal dysfunction, and cholestasis 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 31, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at